Drugs / CD34+ enriched, T Cell Depleted donor stem cell product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01200017 | — | acute lymphoblastic leukemia, acute myeloid leukemia, bone marrow failure syndrome, chronic myeloid leukemia +6 | Christopher Dvorak | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ enriched, T Cell Depleted donor stem cell product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01200017 ↗ |
| Modality | Cell therapy | “stem cell transplant” NCT01200017 ↗ |